
DSC Investment is a Seoul-based venture capital firm founded in 2012, focused on early-stage to growth-stage startups. It is one of the leading VC firms in South Korea, managing over $1 billion in assets across 23 funds, with investments spanning AI, biotech, healthcare, consumer, and deep tech sectors.
Deal activity increased 250% year-over-year (7 deals in the last 12 months). Average disclosed round size is $700.3M (across 46 rounds with reported amounts).
Portfolio
51
Fund Size
—
Top Stage
Series B
Last 12 Mo
6
Team
Junam Kim
Managing Director
Kyungho Lee
Managing Director
Dongwon Shin
Partner
Seongmin Kang
Partner
Dongyoung Park
Investment Analyst
Nahyun Kim
Venture Capitalist & Investment Analyst
Jaehyun Hong
Venture capitalist
Ji Park
Investor
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| Ipo | — | Apr 2026 | |
| Series B | — | Feb 2026 | |
| Series B | $312M | Jan 2026 | |
| BBreeze Bio | Series B | $60M | Jan 2026 |
| Unknown | — | Dec 2025 | |
| PPinetree Therapeutics, Inc. | Series B | $47M | Oct 2025 |
| Series B | — | Aug 2025 | |
| Series B | $42M | Jul 2025 | |
| Series B | — | May 2025 | |
| Series C | $7.5M | Apr 2025 | |
| Unknown | — | Jan 2025 | |
| Series A | $8.1M | Jan 2025 | |
| Series A | $2.7M | Jan 2025 | |
| Series A | $17M | Jul 2024 | |
| DDalpha | Seed | — | Apr 2024 |
| Series C | $23.4M | Jan 2024 | |
| Series A | $20M | Dec 2023 | |
| FFreeWillin | Series B | — | Jul 2023 |
| Series A | — | May 2023 | |
| Unknown | — | Jan 2023 | |
| Series B | — | Jan 2023 | |
| GGoPizza | Unknown | $20M | Oct 2022 |
| Series A | $23.5M | Jun 2022 | |
| Series C | $99.4M | Jan 2022 | |
| Series D | — | Jan 2022 |
Top Co-Investors
Last updated: 7 September 2026